首页 /科研细胞 /科研细胞 /科研细胞 /HCC1599(人乳腺原发性导管癌)

HCC1599(人乳腺原发性导管癌)

CBP60415

询 价
索取STR
产品描述
产品数据库
I. General information 
Synonyms: HCC1599
Background: The HCC1599 breast cancer cell line was initiated on March 28, 1995, and took 10 months to establish.
Species: Homo sapiens, human
Tissue: mammary gland; breast/duct
Disease: TNM stage IIIA, grade 3, primary ductal carcinoma
Gender: female, 44 years adult,  Caucasian, White
Morphology: epithelial
Growth Mode: suspension, multicell aggregates
Doubling Time: N/A
DNA Profile: Amelogenin: X
CSF1PO: 12
D13S317: 11
D16S539: 12,13
D5S818: 12
D7S820: 10,11
THO1: 9.3
TPOX: 8
vWA: 17
Cobioer’s Cell Line Authentication Service
Culture Medium:

RPMI1640+20%FBS

HCC1599完全培养基,# CBP60415M
We strongly suggest to purchase the complete medium from Cobioer.

Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: N/A
Receptor Expression: estrogen receptor, negative
progesterone receptor, negative
Oncogene: her2/neu -, p53 -
Genes Expressed: Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Cellular Products: Epithelial glycoprotein 2 [EGP2]; cytokeratin 19
Tumor Formation: N/A
Comments: The tumor was classified as a TNM stage IIIA, grade 3, invasive ductal carcinoma. Information regarding lymph node metastasis is not available.
The cells are poorly differentiated.
The cells are negative for expression of Her2-neu and for expression of p53.
The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR).
HCC1599 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2), and for cytokeratin 19.
An EBV-transformed lymphoblastoid cell line (HCC1599 BL) from the same patient is available as ATCC CRL-2332.
For more information, please contact Cobioer (4008-750-250).

药靶模型联系方式: 华东销售经理:18240630236 全国销售经理:18066071954
诊断标准品联系方式: 华东销售经理:15000320447 华北销售经理:18131625521 华南销售经理:13484295986 华中&西南销售经理:13871580511 全国销售经理:13484295986

扫二维码

立即提交